Survey of polypharmacy prescription in a tertiary care hospital, belagavi

  Polypharmacy is the use of four or more medications in one prescription or implies the prescription of too many medications for an individual. Concerns about polypharmacy include increase adverse drug reactions, drug interactions, prescribing cascade and higher cost. Objectives: To conduct a prescription survey of polypharmacy in tertiary care hospital at Belagavi. Methodology: The study was conducted in the Medicine outpatient department of a tertiary care hospital, Belagavi, after obtaining approval and clearance from the Institutional Ethics Committee. Total 83 patients were selected by Simple Random Sampling and the data were collected prospectively by direct observation in specially designed proforma containing relevant patient details like registration number, age, gender and diagnosis, disease data and drug data. Results: Out of the total sample population (N=83), 56.62% had prescriptions falling under major polypharmacy (>6 drugs), 43.37% had prescriptions categorized as minor polypharmacy (3-5 drugs). The most common age group of patients receiving prescriptions with polypharmacy was between 41 to 60 years accounting for 38.55%. Majority of the patients receiving prescriptions with polypharmacy in our study were females (59.03%) as compared to males (40.96%). Major polypharmacy is more prevalent in patients receiving treatment for Hypertension (60.24%) followed by patients with diabetes (23.67%). Conclusion: Our prescription survey portrays polypharmacy to be widely prevalent in a tertiary care setting. Specific treatment goals with certainty are the essential need for curing diseases rather than polypharmacy, which could be a possible threat of more harm than good

Recent Advances in Sugarcane Industry Solid By-Products Valorization

Sugarcane is among the leading agricultural crop cultivated in tropical regions of the world. Industrial processing of sugarcane generates sugar; as well as various solid wastes (i.e. sugarcane bagasse, pressmud). Improvement of biotechnology in industrial level, offers opportunities for economic utilization of these solid residues. In the last few decades, sugarcane bagasse and pressmud have been explored in the theme of lignocellulosic bioconversion. The recalcitrance of biomass is a major drawback towards successful exploitation of lignocellulosic residues. Pretreatment by suitable/efficient processes can overcome this limitation. In this regards; physical, chemical and biological treatment systems are brought into our perspective. Chemical and physicochemical methods are capital-intensive but not environment-friendly, in contrast, method like biological treatment is eco-friendly but extremely slow. There are still major technological and economic challenges need to be addressed; e.g. bioprospecting, established more reliable genetically modified microorganisms, upgrade gene cloning and sequencing processes, yield improvement at large scale etc. Productions of value-added products from these solid wastes are discussed in such a way that pinpoints the most recent trends and the future directions. Biofuels, enzymes, organic acids and bio-sorbents production draw a clear sketch of the current and future bio-based products. Nano-biotechnology and genetic engineering could be future trends to improved processes and products. This review serves as a valuable reference material for a wide range of scientists and technologists in the relevant fields